|
How do you define ‘old’?
Ahmedabad Mirror Nevertheless, medicine has made numerous strides to increase life expectancy and the expectancy in India is approximately 65 years. Ageing is actually a biological process affecting all cellular function, making them less efficient. Ageing is … |
What's Driving the Surge in Drug Research for "Orphan" Diseases? – Healthline – Healthline
 Healthline |
What’s Driving the Surge in Drug Research for “Orphan” Diseases? – Healthline
Healthline For example, Biogen Idec’s drug Rituximab, a breakthrough treatment for B-cell lymphoma, is projected to generate $34 billion in revenue, according to Thomson Reuters. The drug has since proven helpful in treating rheumatoid arthritis, multiple … |
Leukaemia cure lies in cancer pill? – Times of India
Leukaemia cure lies in cancer pill?Times of IndiaCity scientists Aditi Karmakar, Sudeshna Gangopadhyay and GS Bhattacharya have found out that rapamycin – a drug commonly used in the treatment of liver cancer – inhibits mTOR, the pathway for a multi-dr…
'Off-the-shelf' virus-specific T-cells fight viral infections in stem cell … – BCM News
 TopNews Arab Emirates |
‘Off-the-shelf’ virus-specific T-cells fight viral infections in stem cell …
BCM News They used cells from 18 of these lines to treat 50 patients from eight centers across the country that had undergone a stem cell transplant and were suffering from a severe viral infection that had not responded to conventional treatment. Commonly … Majority of children readmitted to hospital after stem cell transplantOncology Nurse Advisor Nobel Prize Rockets Stem Cell Program to New HeightsUCSF News Services Derriford Hospital’s £3m stem cell isolation unit praisedBBC News Proactive Investors USA & Canada all 17 news articles » |
Cancer may become killer disease by 2015: experts – The Hindu
The HinduCancer may become killer disease by 2015: expertsThe HinduDescribing the cancers of breast, lung, colon and prostate as lifestyle diseases, he said essentially what was happening in the West 20-25 years ago was happening in India now. Control …
Turn Mahalaxmi race course into a park: Sena – Livemint
 Livemint |
Turn Mahalaxmi race course into a park: Sena
Livemint The lease, held by the Royal Western India Turf Club (RWITC), one of the Mumbai’s most exclusive clubs, expires on 31 May. On 4 May, city … Debi Goenka, executive trustee of non-profit organization Conservation Action Trust that lobbies for … Convert Mumbai’s Mahalaxmi Race Course into theme park, says Uddhav …NDTV |
Giant Retailers Agree to Improve Safety at Bangladesh Garment Factories – FairWarning
|
Giant Retailers Agree to Improve Safety at Bangladesh Garment Factories
FairWarning U.S. prosecutors said the guilty plea by Ranbaxy USA Inc., a unit of India’s largest pharmaceutical company, represents the largest financial penalty against a generic drug company for violations of the Food, Drug and Cosmetic Act, which prohibits the … |
Competing Antibodies May Have Hindered Thai HIV Vaccine – AIDSmeds.com HIV/AIDS Treatment News
Competing Antibodies May Have Hindered Thai HIV VaccineAIDSmeds.com HIV/AIDS Treatment NewsNew research on the Thai HIV vaccine trial that was shuttered in 2009 has found that two of the antibodies the vaccine prompted actually worked against one anoth…
Alstoe launches chewable Tempora for heart failure – Zenopa – Zenopa
Alstoe launches chewable Tempora for heart failure – ZenopaZenopaAccording to estimates, degenerative mitral valve disease is the underlying cause of 75 percent of chronic heart failure cases among canines, making Tempora a potentially important new th…
AbbVie grabs rights to biotech startup's anti-gluten drug for $70M upfront – FierceBiotech
|
AbbVie grabs rights to biotech startup’s anti-gluten drug for $70M upfront
FierceBiotech AbbVie is partnered with biotech heavyweight Biogen Idec ($BIIB) on the development therapy for multiple sclerosis known as daclizumab, for instance, and the pharma company has grabbed rights to a drug from Enanta Pharmaceuticals ($ENTA) for use in … |